Evoke Wealth’s DexCom DXCM Stock Holding History

Evoke Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$459K	Sell	7,304 -97	-1%	-$6.75K	0.01%	426
2025 Q4	$491K	Buy	7,401 +944	+15%	+$61K	0.01%	394
2025 Q3	$434K	Sell	6,457 -464	-7%	-$36.7K	0.01%	400
2025 Q2	$604K	Buy	+6,921	New	+$542K	0.01%	309
2022 Q4	–	Sell	-996	Closed	-$80K	–	591
2022 Q3	$80K	Sell	996 -257	-21%	-$21.8K	﹤0.01%	446
2022 Q2	$93K	Sell	1,253 -647	-34%	-$59K	﹤0.01%	422
2022 Q1	$243K	Buy	1,900 +352	+23%	+$38.5K	0.01%	317
2021 Q4	$208K	Sell	1,548 -8	-0.5%	-$1.15K	0.01%	358
2021 Q3	$212K	Sell	1,556 -192	-11%	-$24.2K	0.01%	334
2021 Q2	$187K	Buy	1,748 +1,668	+2,085%	+$160K	0.01%	357
2021 Q1	$7K	Buy	80 +48	+150%	+$4.51K	﹤0.01%	760
2020 Q4	$3K	Hold	32	–	–	﹤0.01%	813
2020 Q3	$3K	Hold	32	–	–	﹤0.01%	763
2020 Q2	$3K	Buy	+32	New	+$2.86K	﹤0.01%	781

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Evoke Wealth's DXCM Position: Q1 2026 in Review

Evoke Wealth reduced its DexCom (DXCM) stake by 1.3% in Q1 2026, selling an estimated $6.75K and leaving 7,304 shares worth $459K. The position accounts for 0.01% of the portfolio, ranked #426.

Evoke Wealth first reported a position in DXCM in Q2 2020 and has held it in 14 quarters since. The position peaked at $604K in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Evoke Wealth held 7,304 shares of DexCom worth $459K as of Q1 2026.
Evoke Wealth sold 97 DexCom shares in Q1 2026, an estimated $6.75K.
DexCom made up 0.01% of Evoke Wealth's portfolio in Q1 2026, its #426 holding.
Evoke Wealth first reported a position in DexCom in Q2 2020 and has held it in 14 quarters since.
Evoke Wealth's DexCom position peaked at $604K in Q2 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.